Cover Image

Understanding and targeting centrally mediated visceral pain in inflammatory bowel disease

Saved in:

Bibliographic Details
Main Authors:	Kristen Elise Farrell (Author), Robert J Callister (Author), Simon eKeely (Author)
Format:	Book
Published:	Frontiers Media S.A., 2014-03-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Pharmacists' Confidence in Managing Patients with Inflammatory Bowel Disease
by: Sharmila S. Prasad, et al.
Published: (2020)

P2Y12 receptor as a new target for electroacupuncture relieving comorbidity of visceral pain and depression of inflammatory bowel disease
by: Yanzhen Li, et al.
Published: (2021)

A Role for Primary Care Pharmacists in the Management of Inflammatory Bowel Disease? Lessons from Chronic Disease: A Systematic Review
by: Sharmila S. Prasad, et al.
Published: (2020)

Electroacupuncture Reduces Visceral Pain Via Cannabinoid CB2 Receptors in a Mouse Model of Inflammatory Bowel Disease
by: Hong Zhang, et al.
Published: (2022)

Advanced Understanding of Monogenic Inflammatory Bowel Disease
by: Ryusuke Nambu, et al.
Published: (2021)

Are adipocytokines inflammatory or metabolic mediators in patients with inflammatory bowel disease?
by: Kahraman R, et al.
Published: (2017)

Receptor-mediated targeted drug delivery systems for treatment of inflammatory bowel disease: Opportunities and emerging strategies
by: Peng Liu, et al.
Published: (2021)

Lactoferrin-mediated macrophage targeting delivery and patchouli alcohol-based therapeutic strategy for inflammatory bowel diseases
by: Yuge Zhao, et al.
Published: (2020)

PLGA-based macrophage-mediated drug targeting for the treatment of visceral leishmaniasis
by: Swati Gupta, et al.
Published: (2017)

Understanding palliative care learning: A narrative inquiry exploring health care professionals' memorable experiences
by: Frances Kilbertus, et al.
Published: (2022)

VISCERAL ABDOMINAL PAIN AND OPPORTUNITIES OF SPASMOLYTIC TREATMENT
by: E.A. Kornienko, et al.
Published: (2008)

VISCERAL ABDOMINAL PAIN AND OPPORTUNITIES OF SPASMOLYTIC TREATMENT
by: E.A. Kornienko, et al.
Published: (2008)

The puzzling inflammatory bowel disease: growing interest for mediators of inflammation
by: F. J. Zijlstra
Published: (1997)

Improving Equity of Access Through Electronic Consultation: A Case Study of an eConsult Service
by: Clare Liddy, et al.
Published: (2019)

The Importance of Visceral Hypersensitivity in Irritable Bowel Syndrome-Plant Metabolites in IBS Treatment
by: Ewa Dudzińska, et al.
Published: (2023)

The common pathways and targeted drugs for psoriasis and inflammatory bowel disease
by: Jinsheng LI, et al.
Published: (2022)

Opportunities to Target T Cell Trafficking in Pediatric Inflammatory Bowel Disease
by: Eirini Giannoudaki, et al.
Published: (2021)

Pharmacogenetics in inflammatory bowel disease: understanding treatment response and personalizing therapeutic strategies
by: Yamamoto-Furusho JK
Published: (2017)

Intestinal anti-inflammatory and visceral analgesic effects of a Serpylli herba extract in an experimental model of irritable bowel syndrome in rats
by: Antonio Jesús Ruiz-Malagón, et al.
Published: (2022)

Biopsychosocial Correlates of Presence and Intensity of Pain in Adolescents With Inflammatory Bowel Disease
by: Lexa K. Murphy, et al.
Published: (2020)

The Bowel Microbiota and Inflammatory Bowel Diseases
by: Gerald W. Tannock
Published: (2010)

RIPK2 as a New Therapeutic Target in Inflammatory Bowel Diseases
by: Hajime Honjo, et al.
Published: (2021)

Tackling Inflammatory Bowel Diseases: Targeting Proinflammatory Cytokines and Lymphocyte Homing
by: Yijie Song, et al.
Published: (2022)

Special Issue "Gut Microbiota, Inflammatory Bowel Diseases, and Therapeutic Targets"
by: Eirini Filidou, et al.
Published: (2023)

Metalloproteinases in Inflammatory Bowel Diseases
by: Marônek M, et al.
Published: (2021)

The prevalence of radiographic sacroiliitis in patients affected by inflammatory bowel disease with inflammatory low back pain
by: M. Podswiadek, et al.
Published: (2004)

Pharmacological Targets of Kaempferol Within Inflammatory Pathways-A Hint Towards the Central Role of Tryptophan Metabolism
by: Stefanie Hofer, et al.
Published: (2020)

Ileocolonic-Targeted JAK Inhibitor: A Safer and More Effective Treatment for Inflammatory Bowel Disease
by: Vipul Yadav, et al.
Published: (2022)

Herpes Simplex Proctitis Mimicking Inflammatory Bowel Disease in a Teenaged Male
by: Kristen E. Sandgren, et al.
Published: (2017)

Recent Progress in the Diagnosis and Precise Nanocarrier-Mediated Therapy of Inflammatory Bowel Disease
by: Wang L, et al.
Published: (2021)

The differentiation of amebic colitis from inflammatory bowel disease on endoscopic mucosal biopsies
by: Reecha Singh, et al.
Published: (2015)

Peroxisome Proliferator-Activated Receptors: Experimental Targeting for the Treatment of Inflammatory Bowel Diseases
by: Juan Decara, et al.
Published: (2020)

Trends in Targeted Therapy Usage in Inflammatory Bowel Disease: TRENDY Study of ENEIDA
by: Celia Gómez-Labrador, et al.
Published: (2024)

Case Report: Biologic graft placement with subsequent radiation therapy following radical vulvectomy for adenoid cystic carcinoma of the Bartholin's gland
by: Keely Ulmer, et al.
Published: (2021)

NONORGANIC PAIN AND VISCERAL HYPERALGESIA IN CHILDHOOD
by: Ileana Ioniuc, et al.
Published: (2013)

Purinergic mechanosensory transduction and visceral pain
by: Burnstock Geoffrey
Published: (2009)

Roles of β- and α2-Adrenoceptors Within the Central Nucleus of the Amygdala in the Visceral Pain-Induced Aversion in Rats
by: Satoshi Deyama, et al.
Published: (2010)

Inflammatory Bowel Disease
Published: (2012)

Inflammatory Bowel Disease
by: David B. Sachar, et al.
Published: (2012)

New Frontiers in Therapeutic Drug Monitoring of Biologics in Inflammatory Bowel Disease and Other Immune-Mediated Inflammatory Diseases
Published: (2023)